Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen A Clark

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 23, 2026
First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023Kirsty Foster, Emma J Heymer, Helen Campbell, et al.
The Journal of Infection|March 31, 2016
Differences between culture & non-culture confirmed invasive meningococci with a focus on factor H-binding protein distributionStephen A Clark, Aiswarya Lekshmi, Jay Lucidarme, et al.
The Journal of Infectious Diseases|May 24, 2019
Potentiation of Phase Variation in Multiple Outer-Membrane Proteins During Spread of the Hyperinvasive Neisseria meningitidis Serogroup W ST-11 LineageLuke R Green, Neelam Dave, Adeolu B Adewoye, et al.
The Journal of Infection|September 9, 2023
Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in EnglandStephen A Clark, Helen Campbell, Sonia Ribeiro, et al.
Plos One|May 31, 2018
Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccinesCaroline Cayrou, Ayodeji A Akinduko, Evgeny M Mirkes, et al.
Diagnostic Microbiology and Infectious Disease|June 15, 2025
Interlaboratory study to assess precision and reproducibility of the meningococcal antigen surface expression (MEASURE) assay to quantify factor H binding protein expression at the surface of meningococcal serogroup B strainsJakob Loschko, Paul Liberator, Jamie Findlow, et al.
Vaccine|March 31, 2025
Characterization of Canadian Neisseria meningitidis serogroup B isolates and factor-H binding protein expression, data from the Canadian Immunization Monitoring Program Active (IMPACT), 2013-2020Kevin Meesters, Manish Sadarangani, Stephen A Clark, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 25, 2025
Use of 4CMenB vaccine in the control of an outbreak of serogroup B invasive meningococcal disease in an elderly care home, England, November 2023Emma J Heymer, Stephen A Clark, Helen Campbell, et al.
BMC Infectious Diseases|June 16, 2019
Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017)Shamez N Ladhani, Helen Campbell, Jay Lucidarme, et al.
The Journal of Infection|November 28, 2021
Invasive serogroup B meningococci in England following three years of 4CMenB vaccination - First real-world dataJay Lucidarme, Xilian Bai, Aiswarya Lekshmi, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 23, 2026
First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023Kirsty Foster, Emma J Heymer, Helen Campbell, et al.
The Journal of Infection|March 31, 2016
Differences between culture & non-culture confirmed invasive meningococci with a focus on factor H-binding protein distributionStephen A Clark, Aiswarya Lekshmi, Jay Lucidarme, et al.
The Journal of Infectious Diseases|May 24, 2019
Potentiation of Phase Variation in Multiple Outer-Membrane Proteins During Spread of the Hyperinvasive Neisseria meningitidis Serogroup W ST-11 LineageLuke R Green, Neelam Dave, Adeolu B Adewoye, et al.
The Journal of Infection|September 9, 2023
Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in EnglandStephen A Clark, Helen Campbell, Sonia Ribeiro, et al.
Plos One|May 31, 2018
Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccinesCaroline Cayrou, Ayodeji A Akinduko, Evgeny M Mirkes, et al.
Diagnostic Microbiology and Infectious Disease|June 15, 2025
Interlaboratory study to assess precision and reproducibility of the meningococcal antigen surface expression (MEASURE) assay to quantify factor H binding protein expression at the surface of meningococcal serogroup B strainsJakob Loschko, Paul Liberator, Jamie Findlow, et al.
Vaccine|March 31, 2025
Characterization of Canadian Neisseria meningitidis serogroup B isolates and factor-H binding protein expression, data from the Canadian Immunization Monitoring Program Active (IMPACT), 2013-2020Kevin Meesters, Manish Sadarangani, Stephen A Clark, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 25, 2025
Use of 4CMenB vaccine in the control of an outbreak of serogroup B invasive meningococcal disease in an elderly care home, England, November 2023Emma J Heymer, Stephen A Clark, Helen Campbell, et al.
BMC Infectious Diseases|June 16, 2019
Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017)Shamez N Ladhani, Helen Campbell, Jay Lucidarme, et al.
The Journal of Infection|November 28, 2021
Invasive serogroup B meningococci in England following three years of 4CMenB vaccination - First real-world dataJay Lucidarme, Xilian Bai, Aiswarya Lekshmi, et al.
Pageof 4